BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 19040180)

  • 1. Enhanced oral bioavailability of puerarin using microemulsion vehicle.
    Wu H; Lu C; Zhou A; Min Z; Zhang Y
    Drug Dev Ind Pharm; 2009 Feb; 35(2):138-44. PubMed ID: 19040180
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Formulation optimization of self-emulsifying preparations of puerarin through self-emulsifying performances evaluation in vitro and pharmacokinetic studies in vivo.
    Quan DQ; Xu GX
    Yao Xue Xue Bao; 2007 Aug; 42(8):886-91. PubMed ID: 17944241
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization and evaluation of self-microemulsifying sustained-release pellet formulation of puerarin for oral delivery.
    Zhang Y; Wang R; Wu J; Shen Q
    Int J Pharm; 2012 May; 427(2):337-44. PubMed ID: 22366381
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pharmacokinetics and bioavailability of Puerarin self-microemulsion in Beagle dogs].
    Chen XX; Yuan S; Li G; Liang YY; Zhou X; Xie CS; Long CF
    Zhong Yao Cai; 2011 May; 34(5):750-3. PubMed ID: 21954564
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Formulation optimization and bioavailability after oral and nasal administration in rabbits of puerarin-loaded microemulsion.
    Yu A; Wang H; Wang J; Cao F; Gao Y; Cui J; Zhai G
    J Pharm Sci; 2011 Mar; 100(3):933-41. PubMed ID: 20862776
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Preparation of puerarin liposome and its oral absorption in rat].
    Gu YZ; Zhou W; Zhai GX
    Zhong Yao Cai; 2007 Aug; 30(8):970-3. PubMed ID: 18074848
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Preparation of puerarin solid self-microemulsion].
    Yu AH; Zhai GX; Cui J; Liu H
    Zhong Yao Cai; 2006 Aug; 29(8):834-8. PubMed ID: 17076244
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A microemulsion of puerarin-phospholipid complex for improving bioavailability: preparation, in vitro and in vivo evaluations.
    Wu JY; Li YJ; Han M; Hu XB; Yang L; Wang JM; Xiang DX
    Drug Dev Ind Pharm; 2018 Aug; 44(8):1336-1341. PubMed ID: 29513046
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Formulation development and pharmacokinetics of puerarin self-emulsifying drug delivery systems.
    Dong-Qin Q; Gui-Xia X; Xiang-Gen W
    PDA J Pharm Sci Technol; 2007; 61(1):37-43. PubMed ID: 17390702
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms of microemulsion enhancing the oral bioavailability of puerarin: comparison between oil-in-water and water-in-oil microemulsions using the single-pass intestinal perfusion method and a chylomicron flow blocking approach.
    Tang TT; Hu XB; Liao DH; Liu XY; Xiang DX
    Int J Nanomedicine; 2013; 8():4415-26. PubMed ID: 24277986
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preparation and evaluation of ibuprofen-loaded microemulsion for improvement of oral bioavailability.
    Hu L; Yang J; Liu W; Li L
    Drug Deliv; 2011 Jan; 18(1):90-5. PubMed ID: 20942639
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Studies on effect of microemulsion in enhancing solubility of baicalin and puerarin].
    Yang H; Yi H; Li ML; Cao ZY; Feng WH
    Zhongguo Zhong Yao Za Zhi; 2007 Oct; 32(19):1996-9. PubMed ID: 18161289
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preparation, characterization, and pharmacokinetic evaluation of puerarin submicron emulsion.
    Yue PF; Yuan HL; Yang M; You RH; Cong LB; Zhu J; Wang Q; Zhu WF; Xiao XH
    PDA J Pharm Sci Technol; 2008; 62(1):32-45. PubMed ID: 18402366
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and optimization of intravenous puerarin emulsions formation by a novel complex-phase inversion-homogenization technology.
    Yue PF; Yuan HL; Li XY; Yang M; Zhu WF; Xiao XH
    Chem Pharm Bull (Tokyo); 2007 Nov; 55(11):1563-8. PubMed ID: 17978512
    [TBL] [Abstract][Full Text] [Related]  

  • 15. N-trimethyl chitosan (TMC)-modified microemulsions for improved oral bioavailability of puerarin: preparation and evaluation.
    Liao D; Liu X; Dai W; Tang T; Ou G; Zhang K; Han M; Kang R; Yang S; Xiang D
    Drug Deliv; 2015; 22(4):516-21. PubMed ID: 24467620
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of particle size on the pharmacokinetics of puerarin nanocrystals and microcrystals after oral administration to rat.
    Tu L; Yi Y; Wu W; Hu F; Hu K; Feng J
    Int J Pharm; 2013 Dec; 458(1):135-40. PubMed ID: 24120729
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design of fenofibrate microemulsion for improved bioavailability.
    Hu L; Wu H; Niu F; Yan C; Yang X; Jia Y
    Int J Pharm; 2011 Nov; 420(2):251-5. PubMed ID: 21907776
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preparation and In Vitro/In Vivo Evaluation of Puerarin Solid Self-Microemulsifying Drug Delivery System by Spherical Crystallization Technique.
    Cheng G; Hu R; Ye L; Wang B; Gui Y; Gao S; Li X; Tang J
    AAPS PharmSciTech; 2016 Dec; 17(6):1336-1346. PubMed ID: 26694058
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies on preparation and absolute bioavailability of a self-emulsifying system containing puerarin.
    Quan DQ; Xu GX; Wu XG
    Chem Pharm Bull (Tokyo); 2007 May; 55(5):800-3. PubMed ID: 17473473
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Examination of lymphatic transport of puerarin in unconscious lymph duct-cannulated rats after administration in microemulsion drug delivery systems.
    Wu H; Zhou A; Lu C; Wang L
    Eur J Pharm Sci; 2011 Mar; 42(4):348-53. PubMed ID: 21216284
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.